You Position: Home > Paper

Radical efficacy evaluation of comprehensive interventionai therapy for primary hepatocellular carcinoma

( views:403, downloads:18 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF BIOMEDICAL ENGINEERING
Issue:
4
DOI:
10.3760/cma.j.issn.1674-1927.2009.04.005
Key Word:
肝肿瘤;综合治疗;经导管动脉化疗栓塞术;射频消融;经皮无水乙醇注射术;Liver neoplasms;Combined medality therapy;Transeatheter arterial chemoembolization;Radio frequency ablation;Percutaneous ethonal injection

Abstract: Objective To explore the clinical value of interventional invasive therapy in primary hepatocellular carcinoma (PHCC) and it' s radical efficacy. Methods The retrospective analysis was undertaken in 538 patients between January 2003 and January 2008 in our hospital with PHCC. The treatment and the radical efficacy were evaluated. Results Twenty patients(3.7%, 20/538) get progression after the first treatment, 518 patients (518/538) had ever gained effective cure, of whom progression occurred in 416 patients (77.3%, 416/538)at last. The earliest progression occurred 4 months after the first therapy, and the latest occurred 24 months later. One hundred and two (19.0%, 102/538) patients gained evident effective cure, 53 of whom gained radical cure, and they are still alive. The longest follow-up time was 64 months, the shortest was 16 months, and the median survival span estimation in the recent follow-up was 36.5 months. Conclusion Comprehensive interventional therapy is an effective and safe therapy for PHCC, and some patients can gain radical cure.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn